Perioperative anaemia management: Consensus statement on the role of intravenous iron

British Journal of Anaesthesia

Volumn 100, Issue 5, 2008, Pages 599-604

  Beris, P ^a   Munoz M ^b   Garcia Erce J A ^c   Thomas, D ^d   Maniatis, A ^e   Van Der Linden, P ^f  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b School of Medicine of Malaga   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d MORRISTON HOSPITAL   (United Kingdom)

^e HENRY DUNANT HOSPITAL   (Greece)

^f BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood, transfusion; Complications, anaemia; Surgery, cardiac, orthopaedic; Surgery, postoperative period; Surgery, preoperative period

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; HEART SURGERY; HUMAN; IRON THERAPY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PROFESSIONAL PRACTICE; STANDARD; TREATMENT OUTCOME;

ANEMIA; EVIDENCE-BASED MEDICINE; HUMANS; INJECTIONS, INTRAVENOUS; IRON; PERIOPERATIVE CARE; PROFESSIONAL PRACTICE; TREATMENT OUTCOME;

EID: 43249083205     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen054     Document Type: Review

References (45)

1. Andrews CM, Lane DW, Bradley JG. Iron pre-load for major joint replacement. Transfus Med 1997; 7: 281-6
2. Aronoff GR. Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol 2004; 15 (Suppl 2): S99-106
3. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. Br Med J 2004; 328: 1490
4. Bernière J, Dehullu JP, Gall O, Murat I. Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents. Rev Chir Orthop Reparatrice Appar Mot 1998; 84: 319-22
5. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279: 199-205
6. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-82
7. Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994; 23: 493-925
8. Cuenca J, Garcia-Erce JA, Munoz M, Izuel M, Martinez AA, Herrera A. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004; 44: 1447-52
9. Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005; 125: 342-7
10. Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogenic blood after knee replacement surgery. Transfusion 2006; 46: 1112-9
11. Cuenca J, Garcia-Erce JA, Martinez F, Cardona R, Perez-Serrano L, Munoz M. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 2007; 5: 89-94
12. Garcia-Erce JA, Cuenca J, Solano VM. Predictive factors for transfusion requirements in patients over 65 years old with subcapital hip fracture. Med Clin (Barc) 2003; 120: 161-6
13. Garcia-Erce JA, Manuel Solano V, Cuenca J, Ortega P. Preoperative hemoglobin as the only predictive factor of transfusional needs in knee arthroplasty. Rev Esp Anestesiol Reanim 2002; 49: 254-60
14. Garcia-Erce JA, Cuenca J, Munoz M, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 88: 235-43
15. García-Erce JA, Cuenca J, Muñoz M. Role of intravenous iron in elective and non-elective orthopedic surgery. Semin Hematol 2006; 43: S32-5
16. Georgopoulos D, Matamis D, Routsi C, et al. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. Crit Care 2005; 9: R508-15
17. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005; 101: 1858-61
18. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8
19. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-76
20. Hulin S, Durandy Y. Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy. Ann Fr Anesth Reanim 2005; 24: 1262-5
21. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006; 53: 11-9
22. Leal-Noval R, Munoz M, Paramo JA, Garcia-Erce JA. Spanish consensus statement on alternatives to allogenic transfusions: the 'Seville document'. Transfus Alternat Transfus Med 2006; 8: 178-202
23. Lidder PG, Sanders G, Whitehead E, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007; 89: 418-21
24. Macdougall IC. Experience with intravenous iron in nephrology. Semin Hematol 2006; 43: S9-12
25. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18: 59-63
26. Marcucci C, Madjdpour C, Spahn DR. Allogenic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004; 70: 15-28
27. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 2007; 99: 794-800
28. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996; 13: 465-78
29. Mundy GM, Birtwistle SJ, Power RA. The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg Br 2005; 87: 213-7
30. Munoz Gomez M, Campos Garriguez A, Garcia Erce JA, Ramirez Ramirez G. Physiopathology of iron metabolism: diagnostic and therapeutic implications. Nefrologia 2005; 25: 9-19
31. Munoz M, Campos A, García-Erce JA. Intravenous iron in colorectal cancer surgery. Semin Hematol 2006; 43: S36-8
32. Munoz M, Naveira E, Seara J, Palmer JH, Cuenca J, Garcia-Erce JA. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Transfus Med 2006; 16: 137-42
33. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005; 35: 36-40
34. Saleh E, McClelland DB, Hay A, Semple D, Walsh TS. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007; 99: 801-8
35. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116: 58S-69S
36. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20: 273-82
37. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Joint Surg Br 2004; 86: 31-3
38. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM. Intravenous iron following cardiac surgery does not increase the infection rate. Surg Infect (Larchmt) 2006; 7: 361-6
39. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41-5
40. Wallis JP, Wells AW, Whitehead S, Brewster N. Recovery from post-operative anaemia. Transfus Med 2005; 15: 413-8
41. Weatherall M, Maling TJ. Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial. ANZ J Surg 2004; 74: 1049-51
42. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23
43. Wong CJ, Vandervoort MK, Vandervoort SL, et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007; 47: 832-41
44. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-8
45. Zauber NP, Zauber AG, Gordon FJ, et al. Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA 1992; 267: 525-7